E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 357.8 INR 1.83% Market Closed
Market Cap: 256.8B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Emcure Pharmaceuticals Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Emcure Pharmaceuticals Ltd
Cost of Revenue Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Cost of Revenue
-â‚ą26B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cost of Revenue
-â‚ą84.5B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cost of Revenue
-â‚ą87.5B
CAGR 3-Years
-3%
CAGR 5-Years
-9%
CAGR 10-Years
-8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cost of Revenue
-â‚ą104.9B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cost of Revenue
-â‚ą27.5B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
M
Mankind Pharma Ltd
NSE:MANKIND
Cost of Revenue
-â‚ą34B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Emcure Pharmaceuticals Ltd's Cost of Revenue?
Cost of Revenue
-26B INR

Based on the financial report for Mar 31, 2024, Emcure Pharmaceuticals Ltd's Cost of Revenue amounts to -26B INR.

What is Emcure Pharmaceuticals Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-10%

Over the last year, the Cost of Revenue growth was -10%.

Back to Top